15th Annual Pre-Filled Syringes and Injectable Drug Devices Conference

by Stephen Riddle

SAE Media Group’s 15th Annual Pre-Filled Syringes and Injectable Drug Devices Conference 2023 will be bigger than ever, with a pre-conference focus day exploring the advances in PFS design for enhanced drug delivery proceeded by a two-day main conference comprising of morning keynote plenaries and parallel afternoon topic streams as detailed below:

  • Novel Drug Products and Large Volume Delivery
  • Sustainability for Injectable Delivery Devices
  • Primary Packaging Development
  • Connected Drug Delivery Devices

Topics of discussion will include the latest updates in the combination product regulatory framework, insights into the evolving digital health landscape for connected delivery devices, considerations for the development of primary packaging, utilising platform technology, the delivery of novel drug formulations and large volume drug products, patient centric approaches to device design as well as sustainable approaches for device development.

This event will not only bring you key insights you need to expand and enhance your injectable device portfolio but will also give you the opportunity to network with key players throughout the industry.

find out more at http://www.pre-filled-syringes.com/pharmaphorum

Benefits of Attending:

  • Engage with industry representatives on the latest trends within the pre-filled syringe and injectable device market
  • Hear about new technological advances in the delivery of large volume drugs
  • Explore updates to drug device combination product design approaches considering patient preference at the forefront with case studies from big pharma representatives
  • Understand the latest regulatory requirements from regulatory experts surrounding medical devices and digital health
  • Delve into the considerations for material components for the development of primary packaging

Speakers Include:

  • Sebastian Stening, Vice President and Global Head Medical Device Manufacturing Science and Technology, Bayer
  • Abha Violette, Associate Director, Medical Devices and Combination Products, AstraZeneca
  • Theresa Scheuble, Head of Design and Innovation, Johnson & Johnson
  • Claus Geiger, Global Medical Device Leader, Sanofi
  • Carsten Bech, Medical Device Executive, Amgen
  • Joel Richard, Chief Scientific Officer, MedInCell
  • Aaron Gowson, Public Affairs Manager, Chiesi
  • Kim Kristiansen, Principal Scientist, LEO Pharma A/S
  • Eleanor Kimber, Principal Device Engineer, GSK
  • Markus Hemminger, Principal Medical Device Engineer, Roche
  • Olaf Lebau, Device Manager, Boehringer Ingelheim
    Cinzia Federico, New Technologies Device Project Leader, Novartis
  • Amber Witteman, Founder, Managing Director, EPIWatch
  • Blaine Martin, Digital Health, New Product Planning and Portfolio Expansion, Franchise Lead, Fertility, Merck
  • Murray Sayce, Global Head, Sustainability Assurance, BSI Group
  • Marc Moal, Corporate Programme Vice President, Devices and Delivery Solutions, Novo Nordisk
    Steve Hoare, Quality, Regulatory Science & Safety Policy Director, The Association of the British Pharmaceutical Industry (ABPI)
  • Blake Green, Director Regulatory Affairs, Amgen
  • Ravi Kaushik, Vice President, Patient Integrated Care Innovation Platform, Takeda Pharmaceuticals
    Sebastian Gerner, President, Alliance to Zero
  • Shannon Clark, Founder and CEO, UserWise
    Kevin Kusmierek, Scientist, Primary Packaging and Medical Devices, CSL Behring
  • Mitali Aon, VP and Global Head of Device Development, Sanofi
  • Petra Renne, Senior Expert Engineering, Novartis
  • Nima Aghajari, Senior Simulation Engineer, Sanofi
  • Michael Becker, Packaging Engineer, Boehringer Ingelheim
  • Troels Keldmann, DDS Device Consultant and Interim Technical Lead on Injection Devices, LEO Pharma A/S
  • Sean McPike, Senior Consultant, Global HSE, Eli Lilly
  • Niels Otterstrøm Jensen, Head of TakeBack Program, Novo Nordisk A/S Reusable Devices
  • Els Ducheyne, Senior Manager, Materials Compliance, Johnson and Johnson
  • Fatima Bennai-Sanfourche, Senior Director of QA & RA Compliance for Medical Device, Combination Products and eHealth, Bayer
  • Carsten Worsoe, Principal Scientist, Novo Nordisk
  • Danielle Middleton, Associate Medical Director, Patient Safety Physician digital & Devices, AstraZeneca
  • Heinrich Martens, Vice President Regulatory Affairs, Fresenius Kabi
  • Clemens Gunther, Director, Senior Expert Nonclinical Safety, Bayer
  • Klaus Boje, Scientist, Boehringer Ingelheim

SAE Media Group offer direct access to key decision makers through tailored sponsorship and exhibitor packages.

For details, please contact Daniele Moreschi on: +44 (0)20 7827 6050 or [email protected]

For all delegate enquiries, contact Jamie Wilkinson on: +44 (0) 20 7827 6136 or [email protected]

Visit the website where you can find out more, book or download the agenda here:  http://www.pre-filled-syringes.com/pharmaphorum

This post was originally published on Source Link

You may also like